Clinical Trials
16
Active:3
Completed:11
Trial Phases
2 Phases
Phase 1:12
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Phase 1
12 (75.0%)Phase 2
4 (25.0%)Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin
Phase 1
Completed
- Conditions
- ECL-cell HyperplasiaParietal-cell HyperplasiaRebound HyperacidityDyspepsia
- Interventions
- First Posted Date
- 2015-12-03
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- Trio Medicines Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT02620696
YF476 in Barrett's Esophagus
- First Posted Date
- 2015-11-05
- Last Posted Date
- 2021-04-12
- Lead Sponsor
- Trio Medicines Ltd.
- Target Recruit Count
- 27
- Registration Number
- NCT02597712
- Locations
- 🇺🇸
Columbia University, Division of Digestive & Liver Diseases, New York, New York, United States
🇬🇧MRC Cancer Unit, University of Cambridge, Cambridge, Cambridgeshire, United Kingdom
YF476 and Type II Gastric Carcinoids
- First Posted Date
- 2015-05-27
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- Trio Medicines Ltd.
- Target Recruit Count
- 3
- Registration Number
- NCT02454075
Avonex®: Safety, Blood Levels and Effects
Phase 1
Completed
- Conditions
- Multiple Sclerosis (MS)
- First Posted Date
- 2013-05-27
- Last Posted Date
- 2013-05-27
- Lead Sponsor
- Trio Medicines Ltd.
- Target Recruit Count
- 77
- Registration Number
- NCT01863069
- Locations
- 🇬🇧
Hammersmith Medicines Research, London, United Kingdom
Effects of YF476 and Rabeprazole on Gastric Function
Phase 1
Completed
- Conditions
- Hypergastrinaemia
- First Posted Date
- 2012-10-03
- Last Posted Date
- 2012-10-03
- Lead Sponsor
- Trio Medicines Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT01699113
- Locations
- 🇬🇧
Hammersmith Medicines Research, London, United Kingdom
- Prev
- 1
- 2
- 3
- Next
News
No news found